| 08:30 - 10:30 | 41 | Award for Achievement in the field of NSCLC Ceremony (supported by AstraZeneca) followed by Grand Round "How to diagnose and manage NSCLC with the new drugs" - an interactive session | Grand round |
| 08:30 - 10:30 | 42 | Pulmonary injury and repair from alveolus to vessel walls | Symposium |
| 08:30 - 10:30 | 43 | Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?" | Symposium |
| 08:30 - 10:30 | 44 | An Olympic challenge: winners and losers in exercise training | Symposium |
| 08:30 - 10:30 | 45 | Asthma from childhood to adulthood: what factors predict the outcome? | Symposium |
| 08:30 - 10:30 | 46 | Respiratory support in children and young adults with neuromuscular disease | Hot topics |
| 08:30 - 10:30 | 47 | New advances in ICU-acquired weakness | Symposium |
| 08:30 - 10:30 | 48 | Different ways to phenotype asthma | Oral Presentation |
| 08:30 - 10:30 | 49 | Sarcoidosis | Oral Presentation |
| 08:30 - 10:30 | 50 | Chest wall, diaphragm and pleura | Oral Presentation |
| 08:30 - 10:30 | 51 | Diagnostics in OSA: from polygraphy to genetics and cancer | Oral Presentation |
| 08:30 - 10:30 | 52 | Exacerbations of asthma and COPD: assessment, impact and novel treatments | Oral Presentation |
| 08:30 - 10:30 | 53 | MDR- and XDR-TB: epidemiological and public health overview | Oral Presentation |
| 08:30 - 10:30 | 54 | COPD is not a pulmonary disease alone | Poster Discussion |
| 08:30 - 10:30 | 55 | Asthma: risk factors and effect of anti-IgE | Poster Discussion |
| 08:30 - 10:30 | 56 | Pathophysiological mechanisms in disease: new insights | Poster Discussion |
| 08:30 - 10:30 | 57 | Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life | Poster Discussion |
| 08:30 - 10:30 | 58 | Ultrasound in pulmonary medicine: from inside and outside | Poster Discussion |
| 08:30 - 10:30 | 59 | Airway diseases: from invasive to noninvasive biomarkers | Poster Discussion |
| 10:45 - 12:45 | 62 | Cournand Lecture followed by Hot Topic "Early intervention in CF: why, when and how?" | Cournand Lecture |
| 10:45 - 12:45 | 63 | Current challenges in multimodality lung cancer treatment | Symposium |
| 10:45 - 12:45 | 64 | Cochrane reviews in airway diseases | Symposium |
| 10:45 - 12:45 | 65 | Prevention and treatment of infective exacerbations of COPD | Symposium |
| 10:45 - 12:45 | 66 | Searching for the secrets of senescence in the lung | Hot topics |
| 10:45 - 12:45 | 67 | Paediatric lung function today | Symposium |
| 10:45 - 12:45 | 68 | Late breaking results: Asthma from phenotyping to emerging new treatments | Oral Presentation |
| 10:45 - 12:45 | 69 | Asthma and COPD at work: what are the effects of exposure and risk factors? | Oral Presentation |
| 10:45 - 12:45 | 70 | Mechanisms of asthma | Oral Presentation |
| 10:45 - 12:45 | 71 | Pulmonary circulation: clinical databases and registries | Oral Presentation |
| 10:45 - 12:45 | 72 | Functional imaging of the lung parenchyma, tumours and circulation | Oral Presentation |
| 10:45 - 12:45 | 73 | Update on neutrophil and macrophage function in COPD | Oral Presentation |
| 10:45 - 12:45 | 74 | How to use technology to provide better critical care | Oral Presentation |
| 10:45 - 12:45 | 75 | Clinical management of lung diseases: from bronchi to pleura | Poster Discussion |
| 10:45 - 12:45 | 76 | Tuberculosis and immunologic assays | Poster Discussion |
| 10:45 - 12:45 | 77 | CPAP: beneficial effects on different aspects of health | Poster Discussion |
| 10:45 - 12:45 | 78 | Asthma and COPD: quality of life and comorbidities | Poster Discussion |
| 10:45 - 12:45 | 79 | Gene-environment treatment and asthma | Poster Discussion |
| 10:45 - 12:45 | 80 | Physiotherapy and rehabilitative interventions applied to different populations with respiratory impairment | Poster Discussion |
| 12:50 - 14:40 | 81 | Asthma: assessment and treatment | Thematic Poster Session |
| 12:50 - 14:40 | 82 | COPD comorbidities I | Thematic Poster Session |
| 12:50 - 14:40 | 83 | COPD comorbidities II | Thematic Poster Session |
| 12:50 - 14:40 | 84 | Respiratory infections: a clinical point of view | Thematic Poster Session |
| 12:50 - 14:40 | 85 | Respiratory manifestations of systemic disease: a holistic approach | Thematic Poster Session |
| 12:50 - 14:40 | 86 | The latest insights in chronic care | Thematic Poster Session |
| 12:50 - 14:40 | 87 | The latest insights in integrated care | Thematic Poster Session |
| 12:50 - 14:40 | 88 | Standard of care, incidential findings, image acquisition | Thematic Poster Session |
| 12:50 - 14:40 | 89 | From the laser through the stent to the valve: the broad spectrum of interventional pneumology | Thematic Poster Session |
| 12:50 - 14:40 | 90 | Cystic lung diseases: lung granulomatosis | Thematic Poster Session |
| 12:50 - 14:40 | 91 | Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease | Thematic Poster Session |
| 12:50 - 14:40 | 92 | Diagnostic insights and decision making in primary care | Thematic Poster Session |
| 12:50 - 14:40 | 93 | Effectiveness of therapeutic interventions in primary care | Thematic Poster Session |
| 12:50 - 14:40 | 94 | New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease | Thematic Poster Session |
| 12:50 - 14:40 | 95 | Inflammatory mechanisms in COPD | Thematic Poster Session |
| 12:50 - 14:40 | 96 | Cell biology and inflammatory gene expression in chronic lung disease | Thematic Poster Session |
| 12:50 - 14:40 | 97 | The many roads to lung injury | Thematic Poster Session |
| 12:50 - 14:40 | 98 | Exercise capacity: from elite athletes to severe impairment | Thematic Poster Session |
| 12:50 - 14:40 | 99 | New issues in pulmonary function | Thematic Poster Session |
| 12:50 - 14:40 | 100 | Physiology, heart failure and respiration in relation to OSA | Thematic Poster Session |
| 12:50 - 14:40 | 101 | Technology, screening and questionnaires in OSA | Thematic Poster Session |
| 12:50 - 14:40 | 102 | Pulmonary circulation: clinical aspects of PAH and associated PH | Thematic Poster Session |
| 12:50 - 14:40 | 103 | Pulmonary circulation: clinical PAH, registries and treatments | Thematic Poster Session |
| 12:50 - 14:40 | 104 | Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models | Thematic Poster Session |
| 12:50 - 14:40 | 105 | COPD epidemiology | Thematic Poster Session |
| 12:50 - 14:40 | 106 | Healthcare utilisation and treatment of asthma and COPD | Thematic Poster Session |
| 12:50 - 14:40 | 107 | Occupational asthma | Thematic Poster Session |
| 12:50 - 14:40 | 108 | Indoor and outdoor air pollution | Thematic Poster Session |
| 12:50 - 14:40 | 109 | Tobacco dependence and respiratory disease | Thematic Poster Session |
| 12:50 - 14:40 | 110 | Sleep monitoring, lung function and inflammation in childhood | Thematic Poster Session |
| 12:50 - 14:40 | 111 | Mechanisms and risk of childhood asthma and allergy | Thematic Poster Session |
| 12:50 - 14:40 | 112 | Cystic fibrosis (adults and children): risk factors and clinical problems | Thematic Poster Session |
| 12:50 - 14:40 | 113 | Going with the flow: assessment and evaluation of airway function and its role in patient management | Thematic Poster Session |
| 12:50 - 14:40 | 114 | Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests | Thematic Poster Session |
| 12:50 - 14:40 | 115 | Physiotherapy and rehabilitation strategies in respiratory diseases and beyond | Thematic Poster Session |
| 12:50 - 14:40 | 116 | New insights in the physical assessment and therapy of respiratory patients | Thematic Poster Session |
| 12:50 - 14:40 | 117 | Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences | Thematic Poster Session |
| 12:50 - 14:40 | 118 | New aspects of lung cancer biology | Thematic Poster Session |
| 12:50 - 14:40 | 119 | Instructive clinical aspects of thoracic oncology | Thematic Poster Session |
| 12:50 - 14:40 | 120 | Clinical issues in malignant pleural effusions | Thematic Poster Session |
| 12:50 - 14:40 | 121 | Improving education for the healthcare team and patients | Thematic Poster Session |
| 12:50 - 14:40 | 122 | Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management | Thematic Poster Session |
| 13:00 - 14:30 | 124 | Paracetamol and asthma: a causal link? | Symposium |
| 13:00 - 14:30 | 125 | How to control the tobacco industry: how to get our children's lungs into our hearts | Symposium |
| 13:00 - 14:00 | 132 | MP3 Long-term non-invasive respiratory support in infants and children | Meet the Professor |
| 13:15 - 14:30 | 135 | NIV - Meeting the Experts: From state-of-the-art to new technologies | Practical Workshop |
| 14:45 - 16:45 | 139 | Imaging Grand Round: an interactive session | Grand round |
| 14:45 - 16:45 | 140 | Unimodal treatment for nonsmall cell lung cancer: dawn of a renaissance? | Symposium |
| 14:45 - 16:45 | 141 | COPD and OSA: two prevalent diseases related to cardiovascular disease by common mechanism? | Symposium |
| 14:45 - 16:45 | 142 | An ERS/ELF joint session "New tools to assess improvement in respiratory patients: capturing the patient's perspective" | Symposium |
| 14:45 - 16:45 | 143 | Viral respiratory disease in preschool children | Symposium |
| 14:45 - 16:45 | 144 | Autoimmunity in airways disease | Symposium |
| 14:45 - 16:45 | 145 | Reclassification of idiopathic interstitial pneumonias | Symposium |
| 14:45 - 16:45 | 146 | Prognosis and outcome of respiratory infections | Oral Presentation |
| 14:45 - 16:45 | 147 | Asthma: from childhood environment to adult phenotypes | Oral Presentation |
| 14:45 - 16:45 | 148 | Tobacco cessation and tobacco cessation services | Oral Presentation |
| 14:45 - 16:45 | 149 | Solitary pulmonary nodules in the age of lung cancer screening: up and coming endoscopic options | Oral Presentation |
| 14:45 - 16:45 | 150 | Physiological monitoring during sleep and in neuromuscular disease in children | Oral Presentation |
| 14:45 - 16:45 | 151 | New mechanisms in non-neoplastic and neoplastic lung diseases | Oral Presentation |
| 14:45 - 16:45 | 152 | Microbiological advances in the diagnosis of tuberculosis | Poster Discussion |
| 14:45 - 16:45 | 153 | Basic and translational studies in COPD | Poster Discussion |
| 14:45 - 16:45 | 154 | Cystic fibrosis (adults and children): new basic and clinical physiology research | Poster Discussion |
| 14:45 - 16:45 | 155 | The best posters on quality of life and coping styles in COPD | Poster Discussion |
| 14:45 - 16:45 | 156 | Lung transplantation: studies in candidates and recipients | Poster Discussion |
| 14:45 - 16:45 | 157 | Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH | Poster Discussion |